CPI Falls Back over 2Q Australian CPI came in below expected over the 2Q printing 1.9% year over year, well beneath the 2.2% level forecast. Despite the decline underlying measures of inflation, which the RBA focus on, were in line with expectations at 0.5% quarter over quarter. However, annual underlying inflation remains below the bank’s […]

Designing and managing asset allocation strategies based on factors is promoted in some corners as a better way to build portfolios. Not surprisingly, there’s no shortage of studies that support this view. But the jury’s still out on whether it’s prudent to throw out the standard asset-class buckets. Factor-based investing can play a productive role […]

GlaxoSmithKline plc (GSK – Free Report) , one of the largest health care companies, reshaped its business following the Mar 2015 completion of the three-part, inter-conditional transaction with Novartis related to its Consumer Healthcare, Vaccines and Oncology businesses. Under the deal, Glaxo sold its oncology assets to Novartis and acquired Novartis’ Vaccines business (excluding influenza vaccines). […]

The annual inflation rate in Australia slowed down unexpectedly during the 2nd quarter, an indication that the pressure on the cost was decreasing after a sharp shrinkage at the beginning of the year. The Consumer Price Index registered an annual increase of 1.9% in the 2nd quarter, after a 2.1% increase in the previous quarter, […]

As we’re all well aware by now, once Trump was elected on November 8th the Fed suddenly decided it was no longer necessary to prop up asset prices in the United States with artificially low interest rates.As such, they’ve embarked on their first rate-hiking spree since the last one ended just over a decade ago.  […]